DARTBAC is an interdisciplinary, 23 partner consortium consisting of
(a) academic partners with expertise on infection, materials, imaging, in vitro models and social sciences;
(b) technical university partners with expertise on material science, imaging, and in vitro and in vivo test models;
(c) university medical centres with expertise on infection, microbiology, in vitro and in vivo models, imaging, animal models, material technology, and clinical studies;
(d) small and large medical device companies and start-up companies with antimicrobial technologies; (e) scientific societies and knowledge institute of medical specialists with direct access to our target audience and patient groups for communication and dissemination;
(f) the Dutch National Institute for Public Health and the Environment (RIVM) with expertise on materials science and Adverse Outcome Pathways (AOPs); and
(g) an international knowledge platform on AMR with expertise on AMR communication.
